Abstract
To investigate the potential of polymeric nanocapsules for ocular delivery of beta-blockers, several formulations of polyisobutylcyanoacrylate and polyepsiloncaprolactone nanocapsules containing metipranolol base were developed. These formulations differed in the polymer forming the coating and in the type and volume of the oil encapsulated. Analysis of particle-size distribution, electrophoretic mobility, and loading efficiency of the nanocapsules revealed that the type of oil is the most important factor influencing these properties. From the in vitro release studies, we concluded that drug diffusion through a dialysis membrane is delayed as a consequence of the encapsulation process. However, the release profiles were not influenced by the polymeric coating, suggesting that drug release from these systems is governed mainly by the partition of the drug between the oily core and the aqueous release medium. Nevertheless, despite the inability of the polymer coat to control the release of the drug, its contribution to the stabilization of the emulsion was noted. Finally, the suitability of these formulations for ophthalmic administration was investigated. Although the pharmacologic response was not affected by the encapsulated metipranolol compared with the commercial eye drops, a drastic reduction of the drug’s systemic side effects was observed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
P. Couvreur, B. Kante, M. Roland, P. Guiot, P. Baudhuin, and P. Speiser. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: Preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 31:331–332 (1979).
C. Losa, P. Calvo, E. Castro, J. L. Vila Jato, and M. J. Alonso. Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. J. Pharm. Pharmacol. 43:548–552 (1991).
R. Diepold, J. Kreuter, J. Himber, R. Gurny, V. H. L. Lee, J. R. Robinson, M. F. Saettone, and O. E. Schnaudigel. Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles). Graefe's Arch. Clin. Exp. Ophthalmol. 227:188–193 (1989).
R. W. Wood, V. H. K. Li, J. Kreuter, and J. R. Robinson. Ocular disposition of poly-hexyl-2-cyano-(3-14C)acrylate nanoparticle in the albino rabbit. Int. J. Pharm. 23:175–183 (1985).
A. Zimmer, J. Kreuter, and J. R. Robinson. Studies on the transport pathway of PBCA nanoparticles in ocular tissues. J. Microencaps. 8:497–504 (1991).
N. Al-Khouri, L. Roblot-Treupel, H. Fessi, J. P. Devissaguet, and F. Puisieux. Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules. Int. J. Pharmacol. 28:125–132 (1985).
H. Fessi, F. Puisieux, J. P. Devissaget, N. Ammoury, and S. Benita. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55:R1–R4 (1989).
M. Aprahamian, C. Michel, W. Humbert, J. P. Devissaguet, and C. Damge. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol. Cell 61:69–76 (1987).
C. Damge, C. Michel, M. Aprahamian, and P. Couvreur. New approach for oral administration of insulin with polyalkylcy-anoacrylate nanocapsules as drug carrier. Diabetes 37:246–251 (1988).
L. Marchal-Heussler, P. Maincent, M. Hoffman, H. Fessi, and J. P. Devissaguet. Increase of the intraocular hypotensive effect of betaxolol by loading in polycaprolactone nanoparticles and nanocapsules. 9th Pharm. Techn. Conf. Holland 2:10–14 (1990).
New topical β-blockers for glaucoma. Drug Ther. Bull. 25:63–64 (1987).
S. C. Chang, H. Bundgaard, A. Buur, and V. H. L. Lee. Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load. Invest. Ophthalmol. Vis. Sci. 28:487–491 (1987).
W. G. Cochran and G. M. Cox. Experimental Design, John Wiley and Sons, New York, 1962.
R. J. Hunter. Zeta Potential in Colloid Science: Principles and Applications, Academic Press, London, 1981.
E. G. C. Clarke. Clarke's Isolation and Identification of Drugs, Pharmaceutical Society of Great Britain, London, 1986.
P. K. Gupta, C. T. Hung, and D. G. Perrier. The release of doxorubicin from colloidal dosage forms using dynamic dialysis. J. Pharm. Sci. 76:141–145 (1987).
S. R. Douglas, S. S. Davis, and S. R. Holding. Molecular weights of poly(butyl2-cyanoacrylate) produced during nanoparticle formation. Br. Polym. J. 17:339–342 (1985).
N. Ammoury, H. Fessi, J. P. Devissaguet, F. Puisieux, and S. Benita. In vitro release kinetic pattern of indomethacin from poly(D,L-lactide)nanocapsules. J. Pharm. Sci. 79:763–766 (1990).
N. Ammoury, H. Fessi, J. P. Devissaguet, F. Puisieux, and S. Benita. Physicochemical characterization of polymeric nanocapsules and in vitro release evaluation of indomethacin as a drug model. S.T.P. Pharm. 5:647–651 (1989).
J. M. Rollot, P. Couvreur, L. Roblot-Treupel, and F. Puisieux. Physicochemical and morphological characterization of polyisobutylcyanoacrylate nanocapsules. J. Pharm. Sci. 75:361–364 (1986).
P. Fitzgerald, J. Hadgraft, J. Kreuter, and C. G. Wilson. A γ-scintigraphic evaluation of microparticulate ophthalmic delivery systems: Liposomes and nanoparticles. Int. J. Pharmacol. 40:81–84 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Losa, C., Marchal-Heussler, L., Orallo, F. et al. Design of New Formulations for Topical Ocular Administration: Polymeric Nanocapsules Containing Metipranolol. Pharm Res 10, 80–87 (1993). https://doi.org/10.1023/A:1018977130559
Issue Date:
DOI: https://doi.org/10.1023/A:1018977130559